Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

DURECT Corp (NASDAQ:DRRX)

1.25
Delayed Data
As of May 24
 +0.03 / +2.46%
Today’s Change
0.74
Today|||52-Week Range
2.00
-6.72%
Year-to-Date
No recent news for DURECT Corp.

Today’s Trading

Previous close1.22
Today’s open1.21
Day’s range1.20 - 1.26
Volume349,577
Average volume (3 months)687,526
Market cap$173.2M
Dividend yield--
Data as of 3:59pm ET, 05/24/2017

Growth & Valuation

Earnings growth (last year)-36.84%
Earnings growth (this year)+11.54%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)-26.66%
P/E ratioNM
Price/Sales12.72
Price/Book20.67

Competitors

 Today’s
change
Today’s
% change
IMDZImmune Design Corp+0.20+2.70%
OCXOncoCyte Corp-0.40-6.35%
CURRCure Pharmaceutical ...+0.05+0.66%
RDHLRedhill Biopharma Lt...-0.26-2.57%
Data as of 3:59pm ET, 05/24/2017

Financials

Next reporting dateAugust 7, 2017
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$14.0M
Annual profit (last year)-$34.5M
Net profit margin-246.05%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Scientific Officer
Felix Theeuwes
President, Chief Executive Officer &
Director
James E. Brown
Corporate headquarters
Cupertino, California

Forecasts